Healthcare Analysts, along with Professor George Schett, discuss (relevant companies ACET, ALLO, SANA, KYTX RNAC, ARTV, CABA and CRSP) CAR-T in Autoimmune Diseases on an Analyst/Industry conference call to be held on July 30.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACET:
- Adicet Bio’s ADI-270 Gets FDA Fast Track for Cancer Therapy
- Adicet Bio gets fast track designation for ADI-270 to treat ccRCC
- Adicet Bio Advances with FDA Clearance and Upcoming Trial
- Adicet Bio announces FDA clearance of IND application for ADI-270
- Adicet Bio Shareholders Shape Future with Strategic Votes